The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Laboratory Asset Management Is Thriving
Adherents Say These Services Reduce Costs, Decrease Response Times, and Increase Uptime
- Are lab asset management services worth their salt? Millennium Pharmaceuticals (www.mlnm.com) thinks so. A two-year relationship with Thermo Fisher Scientific (www.thermo.com) has trimmed its annual multimillion-dollar maintenance budget by 15–20% compared to what it would have paid the original equipment manufacturer (OEM), according to Jack Parker, associate director of ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.